Home › Funds › SCHOLTZ & COMPANY, LLC › DXCM
SCHOLTZ & COMPANY, LLC position in DXCM
DEXCOM INC · Health Care
SCHOLTZ & COMPANY, LLC reported holding 75,576 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 3.43% of its reported portfolio and ranking #9 among its reported holdings. SCHOLTZ & COMPANY, LLC has disclosed DXCM holdings in 11 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SCHOLTZ & COMPANY, LLC's DXCM position evolved
SCHOLTZ & COMPANY, LLC first disclosed a stake in DXCM in Q4 2023 at 22,539 shares (US$2.8M). The position peaked in Q3 2026 at 75,576 shares, worth US$6.5M. Across 11 filings, SCHOLTZ & COMPANY, LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 75,576 shares valued at US$6.5M — a reduction of -1,758 shares quarter over quarter.. Notable position changes include a 378% increase in Q3 2025 (shares fell 1% over the following quarter), a 114% increase in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 22.54K | $2.80M | New |
| Q1 2024 | 25.80K | $3.58M | Add |
| Q2 2024 | 26.86K | $3.05M | Add |
| Q3 2024 | 25.53K | $1.71M | Reduce |
| Q1 2025 | 6.60K | $450.44K | New |
| Q2 2025 | 6.69K | $583.62K | Add |
| Q3 2025 | 31.95K | $2.15M | Add |
| Q4 2025 | 68.34K | $4.54M | Add |
| Q1 2026 | 68.65K | $4.31M | Hold |
| Q2 2026 | 77.33K | $5.21M | Add |
| Q3 2026 | 75.58K | $6.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 30 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$1.25B), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.52M sh · $1.25B · Q3 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
More on SCHOLTZ & COMPANY, LLC
FAQ
How long has SCHOLTZ & COMPANY, LLC held DXCM?
SCHOLTZ & COMPANY, LLC has disclosed DXCM holdings in 11 of the last 12 reported quarters, going back to Q4 2023.
What is SCHOLTZ & COMPANY, LLC's current position in DXCM?
As of Q3 2026, SCHOLTZ & COMPANY, LLC holds 75.58K shares of DXCM (DEXCOM INC), valued at $6.52M, representing 3.43% of its reported portfolio and ranking #9.
Has SCHOLTZ & COMPANY, LLC been buying or selling DXCM?
In the latest 13F filing (Q3 2026), SCHOLTZ & COMPANY, LLC reduced its position in DXCM. The position peaked in Q3 2026 at 75.58K shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.